Natera Inc Aktie
269,60 €
Deine Einschätzung
Was spricht für und gegen Natera Inc in den nächsten Jahren?
Pro
Kontra
Rendite von Natera Inc im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Natera Inc | -0,40 % | 15,48 % | 16,07 % | 100,36 % | 39,34 % | 433,01 % | 180,10 % |
| Orthofix Medical Inc. | 1,16 % | -16,02 % | -11,28 % | -20,64 % | -32,95 % | -51,40 % | -73,79 % |
| Lantheus Holdings Inc | 0,34 % | -0,46 % | -5,51 % | 89,60 % | 52,97 % | 38,89 % | - |
| IRadimed Corp | -0,66 % | -6,17 % | -11,63 % | 25,62 % | -8,43 % | - | - |
Kommentare
News
What to Know About This Natera Insider Transaction as Shares Surge to Record Highs
Solomon Moshkevich, president of clinical diagnostics at Natera, Inc. (NASDAQ:NTRA), sold 3,410 shares of common stock on August 3, according to an SEC Form 4 filing.
Transaction value based on SEC
A Natera Co-Founder Sold 2,000 Shares From a Spouse's Account. Here's What It Suggests
Executive Chairman Matthew Rabinowitz reported a sale of 2,000 shares of Natera, Inc. (NASDAQ:NTRA) in a recent SEC Form 4 filing.
Transaction value based on SEC Form 4 weighted average sale price
Should You Worry That a Natera Co-Founder Sold Shares? Here's What Long-Term Investors Should Know
Matthew Rabinowitz, the executive chairman of Natera, Inc. (NASDAQ:NTRA), sold 731 shares of common stock at $267.99 per share on August 3, according to an SEC Form 4 filing.
Transaction value based





